Cookie Policy: This site uses cookies to improve your experience. You can find out more about our use of cookies in our Privacy Policy. By continuing to browse this site you agree to our use of cookies.
AdipoGen Life Sciences
MS-275
30
CHF
CHF 30.00
In stock
AG-CR1-0032-M0011 mgCHF 30.00
AG-CR1-0032-M0055 mgCHF 65.00
AG-CR1-0032-M02525 mgCHF 195.00
| Product Details | |
|---|---|
| Synonyms | N-(2-Aminophenyl)-4-[N-(pyridine-3-ylmethoxy-carbonyl)aminomethyl]benzamide; MS-27-275 |
| Product Type | Chemical |
| Properties | |
| Formula |
C21H20N4O3 |
| MW | 376.4 |
| CAS | 209783-80-2 |
| Purity Chemicals | ≥99% (HPLC) |
| Appearance | Off-white to tan solid. |
| Solubility | Soluble in DMSO or methanol. |
| Identity | Determined by 1H-NMR. |
| InChi Key | LTWMTJUZATWRDH-UHFFFAOYSA-N |
| Smiles | NC1=C(NC(=O)C2=CC=C(CNC(=O)OCC3=CC=NC=C3)C=C2)C=CC=C1 |
| Shipping and Handling | |
| Shipping | AMBIENT |
| Short Term Storage | +4°C |
| Long Term Storage | -20°C |
| Handling Advice | Protect from light. |
| Use/Stability | Stable for at least 2 years after receipt when stored at -20°C. |
| Documents | |
| MSDS |
 Download PDF |
| Product Specification Sheet | |
| Datasheet |
Download PDF |
Description
- HDAC 1 inhibitor [1, 2].
- Antitumor compound [1-3].
- Antiproliferative [2].
- TGF-β type II receptor inducer [2].
- Apoptosis inducer [4].
- Anti-inflammatory [5].
- Angiogenesis inhibitor [6].
- Review [7].
- Promotes either self-renewal or differentiation of embryonic stem cells [8].
Product References
- A synthetic inhibitor of histone deacetylase, MS-27-275, with marked in vivo antitumor activity against human tumors: A. Saito, et al.; PNAS 96, 4592 (1999)
- MS-275, a histone deacetylase inhibitor, selectively induces transforming growth factor beta type II receptor expression in human breast cancer cells: B.I. Lee, et al.; Cancer Res. 61, 931 (2001)
- MS-27-275, an inhibitor of histone deacetylase, has marked in vitro and in vivo antitumor activity against pediatric solid tumors: J. Jaboin, et al.; Cancer Res. 62, 6108 (2002)
- The histone deacetylase inhibitor MS-275 promotes differentiation or apoptosis in human leukemia cells through a process regulated by generation of reactive oxygen species and induction of p21CIP1/WAF1 1: R.R. Rosato, et al.; Cancer Res. 63, 3637 (2003)
- MS-275, an histone deacetylase inhibitor, reduces the inflammatory reaction in rat experimental autoimmune neuritis: Z.Y. Zhang, et al.; Neuroscience 169, 370 (2010)
- S-275 sensitizes TRAIL-resistant breast cancer cells, inhibits angiogenesis and metastasis, and reverses epithelial-mesenchymal transition in vivo: R.K. Srivastava, et al.; Mol. Cancer Ther. 9, 3254 (2010)
- MS-275, a potent orally available inhibitor of histone deacetylases--the development of an anticancer agent: H. Hess-Stumpp, et al.; Int. J. Biochem. Cell Biol. 39, 1388 (2007)
- Histone Deacetylase Inhibitors in Cell Pluripotency, Differentiation, and Reprogramming: A. Kretsovali, et al.; Stem Cells Int. 2012, 1 (2012)
Related Products
